Osaic Holdings
ABOS icon

Osaic Holdings’s Acumen Pharmaceuticals ABOS Stock Holding History

Osaic Holdings’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.6K Sell
5,351
-1,500
-22% -$3.83K ﹤0.01% 6149
2025
Q4 		$14.5K Sell
6,851
-400
-6% -$794 ﹤0.01% 6089
2025
Q3 		$10.4K Hold
7,251
– – ﹤0.01% 6333
2025
Q2 		$8.41K Buy
7,251
+2,251
+45% +$2.42K ﹤0.01% 6260
2025
Q1 		$5.5K Sell
5,000
-10,400
-68% -$14.9K ﹤0.01% 6121
2024
Q4 		$26.5K Buy
15,400
+5,000
+48% +$12K ﹤0.01% 5142
2024
Q3 		$25.8K Hold
10,400
– – ﹤0.01% 5210
2024
Q2 		$25.2K Hold
10,400
– – ﹤0.01% 5176
2024
Q1 		$42.1K Buy
10,400
+10,000
+2,500% +$37.7K ﹤0.01% 4866
2023
Q4 		$1.54K Buy
400
+200
+100% +$594 ﹤0.01% 6627
2023
Q3 		$830 Buy
+200
New +$1.24K ﹤0.01% 6877
2022
Q3 		– Sell
-1
Closed – – 7219
2022
Q2 		$0 Buy
+1
New +$4 ﹤0.01% 7293

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $992M AUM 28.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Osaic Holdings's ABOS Position: Q1 2026 in Review

Osaic Holdings reduced its Acumen Pharmaceuticals (ABOS) stake by 22% in Q1 2026, selling an estimated $3.83K and leaving 5,351 shares worth $12.6K. The position accounts for ﹤0.01% of the portfolio, ranked #6149.

Osaic Holdings first reported a position in ABOS in Q2 2022 and has held it in 12 quarters since. The position peaked at $42.1K in Q1 2024. 84 funds tracked by Wall St. Rank hold ABOS as of Q1 2026.

  • Osaic Holdings held 5,351 shares of Acumen Pharmaceuticals worth $12.6K as of Q1 2026.
  • Osaic Holdings sold 1,500 Acumen Pharmaceuticals shares in Q1 2026, an estimated $3.83K.
  • Acumen Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #6149 holding.
  • Osaic Holdings first reported a position in Acumen Pharmaceuticals in Q2 2022 and has held it in 12 quarters since.
  • Osaic Holdings's Acumen Pharmaceuticals position peaked at $42.1K in Q1 2024.
  • 84 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.